UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults

Gastroenterology (New York, N.Y. 1943), 2016-07, Vol.151 (1), p.51-69.e14

2016

Volltextzugriff (PDF)

Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis

The New England journal of medicine, 2016-01, Vol.374 (2), p.124-134

2016

Volltextzugriff (PDF)

Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI)

The Lancet (British edition), 2015-05, Vol.385 (9981), p.1949-1956

2015

Volltextzugriff (PDF)

Randomised controlled trial: susceptibility‐guided therapy versus empiric bismuth quadruple therapy for first‐line Helicobacter pylori treatment

Alimentary pharmacology & therapeutics, 2019-06, Vol.49 (11), p.1385-1394

2019

Volltextzugriff (PDF)

Bioprinted 3D Primary Liver Tissues Allow Assessment of Organ-Level Response to Clinical Drug Induced Toxicity In Vitro

PloS one, 2016-07, Vol.11 (7), p.e0158674-e0158674

2016

Volltextzugriff (PDF)

Antibiotic-loaded, silver core-embedded mesoporous silica nanovehicles as a synergistic antibacterial agent for the treatment of drug-resistant infections

Biomaterials, 2016-09, Vol.101, p.207-216

2016

Volltextzugriff (PDF)

Increased Time to Initial Antimicrobial Administration Is Associated With Progression to Septic Shock in Severe Sepsis Patients

Critical care medicine, 2017-04, Vol.45 (4), p.623-629

2017

Volltextzugriff (PDF)

Porous dressings of modified chitosan with poly(2-hydroxyethyl acrylate) for topical wound delivery of levofloxacin

Carbohydrate polymers, 2016-06, Vol.143, p.90-99

2016

Volltextzugriff (PDF)

Population pharmacokinetics and dose optimization of levofloxacin in elderly patients with pneumonia

British journal of clinical pharmacology, 2024-05, Vol.90 (5), p.1213-1221

2024

Volltextzugriff (PDF)

Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection

Gastroenterology (New York, N.Y. 1943), 2018-10, Vol.155 (4), p.1109-1119

2018

Volltextzugriff (PDF)

Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in China

BMC medicine, 2024-09, Vol.22 (1), p.401-8, Article 401

2024

Volltextzugriff (PDF)

Helicobacter pylori second‐line rescue therapy with levofloxacin‐ and bismuth‐containing quadruple therapy, after failure of standard triple or non‐bismuth quadruple treatments

Alimentary pharmacology & therapeutics, 2015-04, Vol.41 (8), p.768-775

2015

Volltextzugriff (PDF)

Application of Box–Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity

International journal of biological macromolecules, 2016-04, Vol.85, p.258-270

2016

Volltextzugriff (PDF)

The evaluation of the short-term and long-term hydroxychloroquine therapy on ECG parameters

Medicine (Baltimore), 2024-08, Vol.103 (32), p.e39039

2024

Volltextzugriff (PDF)

Fabrication of PLA-Based Nanoneedle Patches Loaded with Transcutol-Modified Chitosan Nanoparticles for the Transdermal Delivery of Levofloxacin

Molecules (Basel, Switzerland), 2024-09, Vol.29 (18), p.4289

2024

Volltextzugriff (PDF)

Inhalable solid lipid nanoparticles of levofloxacin for potential tuberculosis treatment

International journal of pharmaceutics, 2024-07, Vol.660, p.124309, Article 124309

2024

Volltextzugriff (PDF)

Multifunctional pH sensitive 3D scaffolds for treatment and prevention of bone infection

Acta biomaterialia, 2018-01, Vol.65, p.450-461

2018

Volltextzugriff (PDF)

Controlled Release of Antibiotics From Vitamin E–Loaded Silicone-Hydrogel Contact Lenses

Journal of pharmaceutical sciences, 2016-03, Vol.105 (3), p.1164-1172

2016

Volltextzugriff (PDF)

Trial Evaluating Ambulatory Therapy of Travelers’ Diarrhea (TrEAT TD) Study: A Randomized Controlled Trial Comparing 3 Single-Dose Antibiotic Regimens With Loperamide

Clinical infectious diseases, 2017-12, Vol.65 (12), p.2008-2017

2017

Volltextzugriff (PDF)

Novel theranostic wounds dressing based on pH responsive alginate hydrogel/graphene oxide/levofloxacin modified silk

International journal of pharmaceutics, 2024-08, Vol.661, p.124406, Article 124406

2024

Volltextzugriff (PDF)

An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin-association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency

Expert opinion on drug safety, 2019-11, Vol.18 (11), p.1055-1063

2019

Volltextzugriff (PDF)

Glycol chitosan/oxidized hyaluronic acid hydrogel film for topical ocular delivery of dexamethasone and levofloxacin

International journal of biological macromolecules, 2021-01, Vol.167, p.659-666

2021

Volltextzugriff (PDF)

Pediatric tuberculous meningitis: Model-based approach to determining optimal doses of the anti-tuberculosis drugs rifampin and levofloxacin for children

Clinical pharmacology and therapeutics, 2015-12, Vol.98 (6), p.622-629

2015

Volltextzugriff (PDF)

Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization

Colloids and surfaces, B, Biointerfaces, 2016-07, Vol.143, p.168-176

2016

Volltextzugriff (PDF)

Chitosan-coated liposome with lysozyme-responsive properties for on-demand release of levofloxacin

International journal of biological macromolecules, 2024-06, Vol.269 (Pt 2), p.132271-132271, Article 132271

2024

Volltextzugriff (PDF)

1 – 25 von 1.159

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.044)
Mit Volltextzugriff
(936)

Publikationsform

Artikel
(1.154)
magazinearticle
(5)

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Levofloxacin
(962)
Science & Technology
(924)
Humans
(888)
Life Sciences & Biomedicine
(884)
Male
(642)
Anti-Bacterial Agents - Administration & Dosage
(560)
Female
(559)
Ofloxacin - Administration & Dosage
(515)
Middle Aged
(430)
Adult
(384)
Pharmacology & Pharmacy
(365)
Aged
(341)
Treatment Outcome
(296)
Levofloxacin - Administration & Dosage
(287)
Biological And Medical Sciences
(286)
Medical Sciences
(280)
Antibiotics
(261)
Infectious Diseases
(246)
Pharmacology. Drug Treatments
(233)
Anti-Bacterial Agents - Therapeutic Use
(223)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults

Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis

Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI)

Randomised controlled trial: susceptibility‐guided therapy versus empiric bismuth quadruple therapy for first‐line Helicobacter pylori treatment

Bioprinted 3D Primary Liver Tissues Allow Assessment of Organ-Level Response to Clinical Drug Induced Toxicity In Vitro

Antibiotic-loaded, silver core-embedded mesoporous silica nanovehicles as a synergistic antibacterial agent for the treatment of drug-resistant infections

Increased Time to Initial Antimicrobial Administration Is Associated With Progression to Septic Shock in Severe Sepsis Patients

Porous dressings of modified chitosan with poly(2-hydroxyethyl acrylate) for topical wound delivery of levofloxacin

Population pharmacokinetics and dose optimization of levofloxacin in elderly patients with pneumonia

Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection

Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in China

Helicobacter pylori second‐line rescue therapy with levofloxacin‐ and bismuth‐containing quadruple therapy, after failure of standard triple or non‐bismuth quadruple treatments

Application of Box–Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity

The evaluation of the short-term and long-term hydroxychloroquine therapy on ECG parameters

Fabrication of PLA-Based Nanoneedle Patches Loaded with Transcutol-Modified Chitosan Nanoparticles for the Transdermal Delivery of Levofloxacin

Inhalable solid lipid nanoparticles of levofloxacin for potential tuberculosis treatment

Multifunctional pH sensitive 3D scaffolds for treatment and prevention of bone infection

Controlled Release of Antibiotics From Vitamin E–Loaded Silicone-Hydrogel Contact Lenses

Trial Evaluating Ambulatory Therapy of Travelers’ Diarrhea (TrEAT TD) Study: A Randomized Controlled Trial Comparing 3 Single-Dose Antibiotic Regimens With Loperamide

Novel theranostic wounds dressing based on pH responsive alginate hydrogel/graphene oxide/levofloxacin modified silk

An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin-association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency

Glycol chitosan/oxidized hyaluronic acid hydrogel film for topical ocular delivery of dexamethasone and levofloxacin

Pediatric tuberculous meningitis: Model-based approach to determining optimal doses of the anti-tuberculosis drugs rifampin and levofloxacin for children

Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization

Chitosan-coated liposome with lysozyme-responsive properties for on-demand release of levofloxacin

Suchergebnisse filtern